Novavax (NVAX) Assets Average (2011 - 2026)

Novavax's Assets Average history runs 16 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Assets Average fell 22.21% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 22.21% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 18.49% from the prior year.
• Assets Average fell to $1.1 billion in Q1 2026 per NVAX's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Assets Average topped out at $2.7 billion in Q2 2022 and bottomed at $1.1 billion in Q1 2026.
• The 5-year median for Assets Average is $1.6 billion (2024), against an average of $1.8 billion.
• Across the five-year window, Assets Average advanced 29.13% in 2022 and slumped 40.86% in 2023, its largest moves.
• Year by year, Assets Average stood at $2.3 billion in 2022, then fell by 23.67% to $1.7 billion in 2023, then fell by 5.26% to $1.6 billion in 2024, then declined by 28.0% to $1.2 billion in 2025, then dropped by 5.8% to $1.1 billion in 2026.
• Per Business Quant, the three latest NVAX Assets Average figures stand at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025).